Lissette Delgado-Cruzata1, Wenfei Zhang2, Jasmine A McDonald3, Wei Yann Tsai2, Cristina Valdovinos3, Laura Falci3, Qiao Wang4, Katherine D Crew5, Regina M Santella6, Dawn L Hershman5, Heather Greenlee7. 1. Departments of Environmental Health Sciences, Department of Sciences, John Jay College of Criminal Justice, City University of New York, New York, NY. 2. Biostatistics, and. 3. Epidemiology, Mailman School of Public Health. 4. Departments of Environmental Health Sciences. 5. Epidemiology, Mailman School of Public Health, Herbert Irving Comprehensive Cancer Center, and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY; and. 6. Departments of Environmental Health Sciences, Herbert Irving Comprehensive Cancer Center, and. 7. Epidemiology, Mailman School of Public Health, Herbert Irving Comprehensive Cancer Center, and hg2120@columbia.edu.
Abstract
BACKGROUND: Lower levels of global DNA methylation in tissue and blood have been associated with increased cancer risk. Conversely, cross-sectional analyses of healthier lifestyle patterns have been associated with higher levels of global DNA methylation. OBJECTIVE: In this trial, we explored the associations between changes in lifestyle modifications (diet, weight loss), metabolic markers, and global epigenetic biomarkers in white blood cells. METHODS:Study participants were Hispanic, African American, and Afro-Caribbean overweight and sedentary female breast cancer survivors (n = 24) who participated in a larger randomized, crossover, pilot study of a 6-mo weight loss intervention and who had available blood specimens. Anthropometric measures, a food-frequency questionnaire, and peripheral blood were collected at baseline, 6 mo, and 12 mo. Plasma samples were analyzed for metabolic markers (insulin, glucose). We measured DNA methylation of long interspersed nucleotide element 1 (LINE-1) and satellite 2 by pyrosequencing and MethyLight, respectively, and global DNA methylation by the luminometric methylation assay (LUMA). RESULTS:DNA methylation of LINE-1 was statistically significantly elevated at 6 mo [75.5% vs. 78.5% (P < 0.0001)] and 12 mo [75.5% vs. 77.7% (P < 0.0001)], compared to baseline. Over a 12-mo period, changes in percentage body fat andplasma glucose concentrations were positively associated with LINE-1 DNA methylation (β = 0.19, P = 0.001) and LUMA DNA methylation levels (β = 0.24, P = 0.02), respectively. Similarly, 12-mo changes in dietary measures such as vegetable (β = 0.009, P = 0.048), protein (β = 0.04, P = 0.001), and total caloric (β = 0.05, P = 0.01) intake were positively associated with changes in LUMA DNA methylation, as was intake of fruit positively associated with changes in LINE-1 DNA methylation (β = 0.004, P = 0.02). CONCLUSIONS: Our hypothesis-generating results suggest that lifestyle modifications may be associated with changes in global DNA methylation detectable at 6 and 12 mo. These biomarkers may be useful intermediate biomarkers to use in future intervention trials. This trial was registered at clinicaltrials.gov as NCT00811824.
RCT Entities:
BACKGROUND: Lower levels of global DNA methylation in tissue and blood have been associated with increased cancer risk. Conversely, cross-sectional analyses of healthier lifestyle patterns have been associated with higher levels of global DNA methylation. OBJECTIVE: In this trial, we explored the associations between changes in lifestyle modifications (diet, weight loss), metabolic markers, and global epigenetic biomarkers in white blood cells. METHODS: Study participants were Hispanic, African American, and Afro-Caribbean overweight and sedentary female breast cancer survivors (n = 24) who participated in a larger randomized, crossover, pilot study of a 6-mo weight loss intervention and who had available blood specimens. Anthropometric measures, a food-frequency questionnaire, and peripheral blood were collected at baseline, 6 mo, and 12 mo. Plasma samples were analyzed for metabolic markers (insulin, glucose). We measured DNA methylation of long interspersed nucleotide element 1 (LINE-1) and satellite 2 by pyrosequencing and MethyLight, respectively, and global DNA methylation by the luminometric methylation assay (LUMA). RESULTS: DNA methylation of LINE-1 was statistically significantly elevated at 6 mo [75.5% vs. 78.5% (P < 0.0001)] and 12 mo [75.5% vs. 77.7% (P < 0.0001)], compared to baseline. Over a 12-mo period, changes in percentage body fat and plasma glucose concentrations were positively associated with LINE-1 DNA methylation (β = 0.19, P = 0.001) and LUMA DNA methylation levels (β = 0.24, P = 0.02), respectively. Similarly, 12-mo changes in dietary measures such as vegetable (β = 0.009, P = 0.048), protein (β = 0.04, P = 0.001), and total caloric (β = 0.05, P = 0.01) intake were positively associated with changes in LUMA DNA methylation, as was intake of fruit positively associated with changes in LINE-1 DNA methylation (β = 0.004, P = 0.02). CONCLUSIONS: Our hypothesis-generating results suggest that lifestyle modifications may be associated with changes in global DNA methylation detectable at 6 and 12 mo. These biomarkers may be useful intermediate biomarkers to use in future intervention trials. This trial was registered at clinicaltrials.gov as NCT00811824.
Authors: Debra Ting Hsiung; Carmen J Marsit; E Andres Houseman; Karen Eddy; C Sloane Furniss; Michael D McClean; Karl T Kelsey Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-01 Impact factor: 4.254
Authors: Thomas Hillemacher; Helge Frieling; Susanna Moskau; Marc A N Muschler; Alexander Semmler; Johannes Kornhuber; Thomas Klockgether; Stefan Bleich; Michael Linnebank Journal: Eur Neuropsychopharmacol Date: 2008-01-31 Impact factor: 4.600
Authors: Cheryl L Rock; Shirley W Flatt; Loki Natarajan; Cynthia A Thomson; Wayne A Bardwell; Vicky A Newman; Kathy A Hollenbach; Lovell Jones; Bette J Caan; John P Pierce Journal: J Clin Oncol Date: 2005-09-20 Impact factor: 44.544
Authors: Valentina Bollati; Andrea Baccarelli; Lifang Hou; Matteo Bonzini; Silvia Fustinoni; Domenico Cavallo; Hyang-Min Byun; Jiayi Jiang; Barbara Marinelli; Angela C Pesatori; Pier A Bertazzi; Allen S Yang Journal: Cancer Res Date: 2007-02-01 Impact factor: 12.701
Authors: John P Pierce; Marcia L Stefanick; Shirley W Flatt; Loki Natarajan; Barbara Sternfeld; Lisa Madlensky; Wael K Al-Delaimy; Cynthia A Thomson; Sheila Kealey; Richard Hajek; Barbara A Parker; Vicky A Newman; Bette Caan; Cheryl L Rock Journal: J Clin Oncol Date: 2007-06-10 Impact factor: 44.544
Authors: Daniel J Weisenberger; Mihaela Campan; Tiffany I Long; Myungjin Kim; Christian Woods; Emerich Fiala; Melanie Ehrlich; Peter W Laird Journal: Nucleic Acids Res Date: 2005-12-02 Impact factor: 16.971
Authors: Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko Journal: EPMA J Date: 2018-11-12 Impact factor: 6.543
Authors: Heather Greenlee; Ann Ogden Gaffney; A Corina Aycinena; Pam Koch; Isobel Contento; Wahida Karmally; John M Richardson; Zaixing Shi; Emerson Lim; Wei-Yann Tsai; Regina M Santella; William S Blaner; Robin D Clugston; Serge Cremers; Susan Pollak; Iryna Sirosh; Katherine D Crew; Matthew Maurer; Kevin Kalinsky; Dawn L Hershman Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-07-26 Impact factor: 4.254